Physician profile
Anitha Murthy
NPI 1346204021
$1,254.89
in general payments reported to CMS, 2019-2025
13 companies · $344 in 2025
The $344 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $183 · 2020: $95.51 · 2021: $88.68 · 2022: $224 · 2023: $28.43 · 2024: $291 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $663.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $663.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $313.65 | 2022-2024 | Benlysta |
| Otsuka America Pharmaceutical, INC. | $263.25 | 2019-2020 | |
| Vantive US Healthcare LLC | $172.23 | 2025 | |
| Ardelyx, INC. | $154.74 | 2024-2025 | Ibsrela |
| Mallinckrodt Hospital Products INC. | $73.99 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $69.04 | 2021-2025 | Farxiga |
| Amgen INC. | $60.72 | 2022-2024 | Aranesp, Tavneos |
| Novo Nordisk INC | $43.27 | 2025 | Ozempic, Wegovy |
| Lilly USA, LLC | $28.43 | 2023 | Jardiance |
| Akebia Therapeutics INC | $25.50 | 2025 | Vafseo |
| Travere Therapeutics, INC. | $22.22 | 2025 | |
| Fresenius USA Marketing, INC. | $15.71 | 2019 | |
| Vifor Pharma, INC. | $12.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anitha Murthy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.